MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07828cam a2200673 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230529141312.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180802t20192019paua ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
MMU |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
MMU |
| Modifying agency |
USU |
| -- |
OCLCO |
| -- |
UAB |
| -- |
OPELS |
| -- |
OCLCO |
| -- |
CASUM |
| -- |
LEATE |
| -- |
OCLCF |
| -- |
OCLCO |
| -- |
YDX |
| -- |
OCLCA |
| -- |
AU@ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
OPELS |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323596626 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0323596622 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323596640 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0323596649 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323476522 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
032347652X |
| Qualifying information |
(electronic bk.) |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.5/8 |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Brody's human pharmacology : |
| Remainder of title |
mechanism-based therapeutics / |
| Statement of responsibility, etc. |
[edited by] Lynn Wecker ; with David A. Taylor, Robert James Theobald, Jr. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Philadelphia, PA : |
| Name of producer, publisher, distributor, manufacturer |
Elsevier, Inc., |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2019] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xiv, 728 pages) : |
| Other physical details |
color illustrations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh85100599 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chemotherapy. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh85023041 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Humans |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D006801 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D010600 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Therapy |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D004358 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacologie. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chimiothérapie. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
pharmacology. |
| Source of heading or term |
aat |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chemotherapy. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst00853595 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01060259 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wecker, Lynn, |
| Relator term |
editor. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2005181854 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Taylor, David A. |
| Fuller form of name |
(David Alan), |
| Dates associated with a name |
1948- |
| Relator term |
editor. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2018180568 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Theobald, Robert James, |
| Titles and other words associated with a name |
Jr., |
| Relator term |
editor. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2018180565 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/hse.ie?url=https%3a%2f%2fwww.clinicalkey.com%2fdura%2fbrowse%2fbookChapter%2f3-s2.0-C20150057550">https://go.openathens.net/redirector/hse.ie?url=https%3a%2f%2fwww.clinicalkey.com%2fdura%2fbrowse%2fbookChapter%2f3-s2.0-C20150057550</a> |
| Link text |
Access ebook online |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
eBook |
| Suppress in OPAC |
Display on Opac |
| 246 3# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Human pharmacology |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1: Mechanisms of drug action and therapeutic principles. -- Introduction, terminology -- Pharmacodynamics: drug targets (receptors, enzymes, DNA, etc) -- Pharmacokinetics -- Pharmacogenomics -- Drug discovery, development, and regulation -- Section 2: Chemical mediators and drugs affecting autonomic and neuromuscular synapses. -- Introduction to the peripheral nervous systems and drugs for peripheral disorders -- Cholinergic drugs -- Muscarinic agonists and their clinical uses -- Muscarinic antagonists and their clinical uses -- Nicotinic agonists and their clinical uses -- Nicotinic antagonists and neuromuscular blocking drugs -- Adrenergic drugs -- Adrenergic agonists and their clinical uses -- Adrenergic antagonists and their clinical uses -- Section 3: Drug treatment for disorders affecting the central nervous system. Introduction to the CNS and drugs affecting the brain -- Neurodegenerative disorders -- Drug therapy for Alzheimer's disease and other cognitive disorders/dementias -- Pharmacotherapy of basal ganglia disorders: Parkinson's disease and Huntington's disease -- Drug therapy for psychoses and bipolar disorder -- Drug therapy for depression and anxiety -- Drug therapy for the management of attention deficit hyperactivity disorder -- Drug therapy for insomnia and the hypersomnias -- Drug therapy for managing obesity and eating disorders -- Treatment of seizure disorders -- Drug therapy to control spasticity disorders -- Ethanol, other alcohols, and drugs for alcohol use disorder -- Illicit psychoactive compounds and substance use disorder -- Section 4: Drug therapy for pain management. Introduction -- General anesthetics -- Local anesthetics -- Opioid analgesics -- Nonsteroidal anti-inflammatory agents and acetaminophen -- Cannabinoids -- Section 5: Treatment of inflammatory, allergic and immunologic disorders. Drug therapy for migraine headache -- Drug therapy for gout and hyperuricemia -- Drug treatment for allergic reactions -- Immunosuppressants for autoimmune disorders and organ transplantation -- Drug therapy for rheumatoid arthritis -- Section 6: Drug treatment for cardiovascular diseases. Introduction to the cardiovascular system and the regulation of blood pressure and heart rate -- Overview of hypertension management and drugs that decrease sympathetic tone -- Diuretics and drugs that affect volume and electrolyte content -- Drugs affecting the renin-angiotensin-aldosterone system -- Calcium channel blockers -- Vasodilators -- Drug therapy for hyperlipidemias and atherosclerotic cardiovascular disease -- Drug therapy for myocardial ischemia and angina pectoris -- Treatment of heart failure: cardiac glycosides, phosphodiesterase inhibitors and other agents -- Antiarrhythmic drugs -- Anticoagulant, antiplatelet and thrombolytic agents -- Drug therapy for hemophilia and the anemias |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 7: Treatment of endocrine disorders. Introduction to endocrine pharmacology -- Treatment of hypothalamic and pituitary disorders -- Treatment of adrenalcorticosteroid disorders -- Female hormone regulation -- Androgens, antiandrogens and their clinical uses -- Drug therapy for the management of diabetes -- Drug therapy for the management of thyroid disorders -- Calcium regulating hormones and agents affecting bone -- Section 8: Chemotherapy. Infectious diseases -- Principles of antimicrobial use -- Bacterial cell wall synthesis inhibitors -- Inhibitors of protein synthesis -- Drugs that target DNA -- Antimycobacterial drugs and the treatment of tuberculosis and leprosy -- Drug therapy for resistant organisms -- Parasitic diseases -- Antifungal agents -- Antimalarial and other antiprotozoal agents -- Antihelmintics -- Viruses -- Drug therapy for non-HIV viral infections -- Drugs for HIV and related opportunistic infections -- Cancer -- Introduction and therapeutic principles -- Cytotoxic agents -- Targeted agents -- Section 9: Special considerations. Therapeutic use of hematopoietic growth factors, vitamins and minerals -- Gastrointestinal disorders and their treatment -- Pharmacological treatment of asthma and COPD -- The role of neutraceuticals and natural products -- Essentials of toxicology -- Therapeutic considerations for pregnant, pediatric, geriatric and obese individuals. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Focusing on the essential aspects of pharmacology you need to know, Brody's Human Pharmacology, 6th Edition, keeps you fully up to date with all that's new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information"--Publisher's description |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| Non-focus term |
NATCOLCK |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Print version: |
| Title |
Brody's human pharmacology. |
| Edition |
Sixth edition. |
| Place, publisher, and date of publication |
Philadelphia : Elsevier, [2019] |
| International Standard Book Number |
9780323476522 |
| Record control number |
(DLC) 2018003347 |
| -- |
(OCoLC)1021066375 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1046991162 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1046991162 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM300 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 4 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Elsevier |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
|---|
| -- |
Online resource; title from electronic title page (ClinicalKey, viewed August 2, 2018). |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| -- |
Elsevier ClinicalKey eBooks - WAYFless access |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
15711010 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
IEHSE |